Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Article Details
- CitationCopy to clipboard
Jordan A, Hadfield JA, Lawrence NJ, McGown AT
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Med Res Rev. 1998 Jul;18(4):259-96.
- PubMed ID
- 9664292 [ View in PubMed]
- Abstract
Tubulin is the biochemical target for several clinically used anticancer drugs, including paclitaxel and the vinca alkaloids vincristine and vinblastine. This review describes both the natural and synthetic agents which are known to interact with tubulin. Syntheses of the more complex agents are referenced and the potential clinical use of the compounds is discussed. This review describes the biochemistry of tubulin, microtubules, and the mitotic spindle. The agents are discussed in relation to the type of binding site on the protein with which they interact. These are the colchicine, vinca alkaloid, rhizoxin/maytansine, and tubulin sulfhydryl binding sites. Also included are the agents which either bind at other sites or unknown sites on tubulin. The literature is reviewed up to October 1997.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Vinblastine Tubulin alpha-1A chain Protein Humans YesBinderDetails Vinblastine Tubulin beta chain Protein Humans YesBinderDetails Vinblastine Tubulin delta chain Protein Humans YesBinderDetails Vinblastine Tubulin epsilon chain Protein Humans YesBinderDetails Vinblastine Tubulin gamma-1 chain Protein Humans YesBinderDetails